Trial
NCT05167760
Efficacy of Topical Apraclonidine for the Treatment of Ocular Synkinesis
Phase IVWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Alabama at Birmingham
Collaborators
—
Condition
Synkinesis
Intervention
Apraclonidine
Why stopped
The project never opened.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-07-19